Subscribe To
Arbutus biopharma: how will patent win impact stock outlook?
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specializatio...
December 17, 2021, 1:08 pm
Arbutus biopharma: how will patent win impact stock outlook?
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specializatio...
December 17, 2021, 1:08 pm
Arbutus biopharma: how will patent win impact stock outlook?
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company with research specializatio...
December 17, 2021, 1:08 pm
Pfizer requests full approval for covid-19 vaccine for 12- to 15-year-olds
The pharmaceutical company said in November its vaccine gave the age group 100% long-term protection ag...
December 16, 2021, 8:43 pm
Pfizer requests full approval for covid-19 vaccine for 12- to 15-year-olds
The pharmaceutical company said in November its vaccine gave the age group 100% long-term protection ag...
December 16, 2021, 8:43 pm
Pfizer requests full approval for covid-19 vaccine for 12- to 15-year-olds
The pharmaceutical company said in November its vaccine gave the age group 100% long-term protection ag...
December 16, 2021, 8:43 pm
Endo: fda approves generic form of vasostrict creating headwind into next year
Eagle pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP...
December 16, 2021, 1:24 pm
Endo: fda approves generic form of vasostrict creating headwind into next year
Eagle pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP...
December 16, 2021, 1:24 pm
Endo: fda approves generic form of vasostrict creating headwind into next year
Eagle pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP...
December 16, 2021, 1:24 pm
Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022
Arena pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a re...
December 15, 2021, 10:13 pm
Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022
Arena pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a re...
December 15, 2021, 10:13 pm
Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022
Arena pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a re...
December 15, 2021, 10:13 pm
Pfizer stock heads toward record after $6.7 billion takeover of arena; deal ‘makes strategic sense to us,' says analyst
Pfizer Inc. said Monday it has agreed to acquire Arena pharmaceuticals Inc. in a deal with a value of a...
December 13, 2021, 1:18 pm
Pfizer stock heads toward record after $6.7 billion takeover of arena; deal ‘makes strategic sense to us,' says analyst
Pfizer Inc. said Monday it has agreed to acquire Arena pharmaceuticals Inc. in a deal with a value of a...
December 13, 2021, 1:18 pm
Pfizer stock heads toward record after $6.7 billion takeover of arena; deal ‘makes strategic sense to us,' says analyst
Pfizer Inc. said Monday it has agreed to acquire Arena pharmaceuticals Inc. in a deal with a value of a...
December 13, 2021, 1:18 pm
Regeneron stock (regn): $824 price target from goldman sachs
The shares of Regeneron pharmaceuticals Inc (NASDAQ: REGN) have received an $824 price target from Gold...
December 12, 2021, 10:34 am
Regeneron stock (regn): $824 price target from goldman sachs
The shares of Regeneron pharmaceuticals Inc (NASDAQ: REGN) have received an $824 price target from Gold...
December 12, 2021, 10:34 am
Regeneron stock (regn): $824 price target from goldman sachs
The shares of Regeneron pharmaceuticals Inc (NASDAQ: REGN) have received an $824 price target from Gold...
December 12, 2021, 10:34 am
Novartis sees strong interest in sandoz generics unit - finanz und wirtschaft
Novartis is seeing strong interest from private equity investors as well as from other pharmaceuticals ...
December 11, 2021, 8:40 am
Novartis sees strong interest in sandoz generics unit - finanz und wirtschaft
Novartis is seeing strong interest from private equity investors as well as from other pharmaceuticals ...
December 11, 2021, 8:40 am